According to reports from Marketbeat.com, Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares have been given a consensus rating of "Buy" by the fourteen rating...
The CAB will lead and advise Genprex as it advances its REQORSA immunogen therapy program, including its Acclaim clinical trials in non-small cell lung...